Pediatrics Research Group, Institut de Recerca Sant Pau (IR-Sant Pau), Barcelona, Spain; Department of Pediatrics, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Auto-generated profile, based on publicly available information
Marta Pujol-Sanjuan
Pediatrics Research Group, Institut de Recerca Sant Pau (IR-Sant Pau), Barcelona, Spain; Department of Pediatrics, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
And incubated osmotic fragility test), and infections, were unremarkable. Genetic testing targeting hemolytic anemiarelated genes revealed no mutations. The anemia resolved spontaneously in all cases. IP should be considered when pyknocytes appear on neonatal blood smears. It may account for up to 9% of neonatal hemolysis, suggesting potential underdiagnosis [2]. The etiology remains unknown and likely multifactorial [3]. Literature suggests oxidative stress may alter RBC morphology [2, 4]. Hemolysis typically peaks in wk 2-4 and resolves by 4-6 mo [2, 3]. Supportive care remains the primary treatment, with a favorable prognosis.